Landscapes / Companies

Ascendis Pharma Growth Disorders A/S not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
 
Next date
Navepegritide, Phase 2/3 trial completes
Drugs
2
in active trials
Trials
2 active
3 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
—
Ascendis Pharma A/S
Approved Jan 2039Phase 2/3 trial completes
Recombinant human growth hormone
Ascendis Pharma Endocrinology Division A/S
Approved —

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Ascendis Pharma Growth Disorders A/S

Following is part of Solo: you see every change to Ascendis Pharma Growth Disorders A/S the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in